Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.535 USD | +0.43% | -5.22% | +75.25% |
29/04 | Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children | MT |
29/04 | Transcript : Aquestive Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.25% | 320M | |
+30.24% | 662B | |
+21.96% | 546B | |
-5.31% | 359B | |
+16.62% | 323B | |
+4.79% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.18% | 167B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Oppenheimer Initiates Coverage on Aquestive Therapeutics With Outperform Rating, $8.50 Price Target